- China Pacific reported a year-to-date life premium income of 185.96 billion yuan.
- This represents a 9% increase compared to the previous year.
- The year-to-date property and casualty insurance premium income reached 128.63 billion yuan.
- The growth in property and casualty insurance premium income stands at 0.8% year-on-year.
- Current analyst ratings include 18 buys, 5 holds, and no sells.
- All comparisons are based on the company’s original disclosure of past results.
“`
A look at China Pacific Insurance (Group) Co., Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Pacific Insurance (Group) Co. is positioned well for long-term growth, with impressive Smart Scores in Dividend and Growth. Their strong dividend performance signals stability and potential for income-seeking investors. Moreover, scoring high in Growth reflects the company’s capability to expand and increase earnings over time, making it an attractive choice for long-term investors.
Although the company shows resilience in challenging times and has good momentum, there may be room for improvement in these areas. With a solid Value score, China Pacific Insurance (Group) Co. possesses good fundamentals at a reasonable price, which can appeal to value-oriented investors. Overall, based on the Smart Scores, the company seems well-rounded and primed for sustained success in the insurance industry.
### China Pacific Insurance (Group) Company, Ltd. is an integrated insurance services provider. The Company offers life and property insurance products through its subsidiaries. ###
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
